These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 35810798)

  • 1. Lot-to-lot reagent verification: Effect of sample size and replicate measurement on linear regression approaches.
    Koh NWX; Markus C; Loh TP; Lim CY;
    Clin Chim Acta; 2022 Sep; 534():29-34. PubMed ID: 35810798
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of six regression-based lot-to-lot verification approaches.
    Koh NWX; Markus C; Loh TP; Lim CY
    Clin Chem Lab Med; 2022 Jul; 60(8):1175-1185. PubMed ID: 35576605
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detecting long-term drift in reagent lots.
    Liu J; Tan CH; Loh TP; Badrick T
    Clin Chem; 2015 Oct; 61(10):1292-8. PubMed ID: 26272234
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Difference- and regression-based approaches for detection of bias.
    Lim CY; Markus C; Greaves R; Loh TP;
    Clin Biochem; 2023 Apr; 114():86-94. PubMed ID: 36822348
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An approach for determining allowable between reagent lot variation.
    van Schrojenstein Lantman M; Çubukçu HC; Boursier G; Panteghini M; Bernabeu-Andreu FA; Milinkovic N; Mesko Brguljan P; Linko S; Brugnoni D; O'Kelly R; Kroupis C; Lohmander M; Šprongl L; Vanstapel F; Thelen M;
    Clin Chem Lab Med; 2022 Apr; 60(5):681-688. PubMed ID: 35172415
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of the CLSI EP26-A protocol for detection of reagent lot-to-lot differences.
    Katzman BM; Ness KM; Algeciras-Schimnich A
    Clin Biochem; 2017 Sep; 50(13-14):768-771. PubMed ID: 28322754
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lot-to-lot variation and verification.
    Loh TP; Markus C; Tan CH; Tran MTC; Sethi SK; Lim CY
    Clin Chem Lab Med; 2023 Apr; 61(5):769-776. PubMed ID: 36420533
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Research and discussion on the evaluation scheme of reagent lot-to-lot differences in 16 chemiluminescence analytes, established by the EP26-A guidelines of the CLSI.
    Tao R; Zhang C; Liu M; Yang M; Gao W; Chen J; Mo N; Cheng Y; He J; Xie Q
    J Clin Lab Anal; 2021 Mar; 35(3):e23675. PubMed ID: 33274497
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detecting reagent lot shifts using proficiency testing data.
    Tan RZ; Punyalack W; Graham P; Badrick T; Loh TP
    Pathology; 2019 Dec; 51(7):711-717. PubMed ID: 31607378
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison between polynomial regression and weighted least squares regression analysis for verification of analytical measurement range.
    Jeong TD; Kim SK; Kim S; Lim CY; Chung JW
    Clin Chem Lab Med; 2022 Jun; 60(7):989-994. PubMed ID: 35531706
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Failure of internal quality control in detecting significant reagent lot shift in serum creatinine measurement.
    Chen X; Wang J; Zhang W; Xie E; Zhang B; Xu HG
    J Clin Lab Anal; 2019 Nov; 33(9):e22991. PubMed ID: 31373724
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A national surveillance program for evaluating new reagent lots in medical laboratories.
    Solsvik AE; Kristoffersen AH; Sandberg S; Gidske G; Stavelin AV; Eikeland J; Amundsen E
    Clin Chem Lab Med; 2022 Feb; 60(3):351-360. PubMed ID: 35073470
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lot verification practices in Ontario clinical chemistry laboratories - Results of a patterns-of-practice survey.
    Rutledge AC; Johnston A; Booth RA; Veljkovic K; Bailey D; Vandenberghe H; Waite G; Allen LC; Don-Wauchope A; Chan PC; Stemp J; Edmond P; Leung V; Aslan B
    Pract Lab Med; 2022 Nov; 32():e00300. PubMed ID: 36035320
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Statistical validation of reagent lot change in the clinical chemistry laboratory can confer insights on good clinical laboratory practice.
    Cho MC; Kim SY; Jeong TD; Lee W; Chun S; Min WK
    Ann Clin Biochem; 2014 Nov; 51(Pt 6):688-94. PubMed ID: 24497612
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lot-to-lot reagent verification: challenges and possible solutions.
    Loh TP; Sandberg S; Horvath AR
    Clin Chem Lab Med; 2022 Apr; 60(5):675-680. PubMed ID: 35191278
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Commutability limitations influence quality control results with different reagent lots.
    Miller WG; Erek A; Cunningham TD; Oladipo O; Scott MG; Johnson RE
    Clin Chem; 2011 Jan; 57(1):76-83. PubMed ID: 21097677
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Importance of Reagent Lot Registration in External Quality Assurance/Proficiency Testing Schemes.
    Stavelin A; Riksheim BO; Christensen NG; Sandberg S
    Clin Chem; 2016 May; 62(5):708-15. PubMed ID: 26980211
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sample size and rejection limits for detecting reagent lot variability: analysis of the applicability of the Clinical and Laboratory Standards Institute (CLSI) EP26-A protocol to real-world clinical chemistry data.
    Kim S; Chang J; Kim SK; Park S; Huh J; Jeong TD
    Clin Chem Lab Med; 2020 Jul; 59(1):127-138. PubMed ID: 32628625
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of reagent lot-to-lot comparability tests in five immunoassay items.
    Kim HS; Kang HJ; Whang DH; Lee SG; Park MJ; Park JY; Lee KM
    Ann Clin Lab Sci; 2012; 42(2):165-73. PubMed ID: 22585613
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetic parameter estimations by minimum relative entropy method.
    Amisaki T; Eguchi S
    J Pharmacokinet Biopharm; 1995 Oct; 23(5):479-94. PubMed ID: 8656343
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.